Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use

EGb 761(®) (Tanakan(®)) is a standardized extract of Ginkgo biloba leaves that has demonstrated protective properties against neuronal and vascular damage. Overall, in randomized, placebo-controlled clinical trials and meta-analyses in adults with mild-to-moderate dementia, EGb 761(®) displayed posi...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeage, Kate, Lyseng-Williamson, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Adis Drug Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267544/
https://www.ncbi.nlm.nih.gov/pubmed/30546253
http://dx.doi.org/10.1007/s40267-018-0537-8
_version_ 1783376099150921728
author McKeage, Kate
Lyseng-Williamson, Katherine A.
author_facet McKeage, Kate
Lyseng-Williamson, Katherine A.
author_sort McKeage, Kate
collection PubMed
description EGb 761(®) (Tanakan(®)) is a standardized extract of Ginkgo biloba leaves that has demonstrated protective properties against neuronal and vascular damage. Overall, in randomized, placebo-controlled clinical trials and meta-analyses in adults with mild-to-moderate dementia, EGb 761(®) displayed positive effects, with changes from baseline in outcomes related to cognition, behaviour and global change that are generally better than those shown with placebo. EGb 761(®) is generally well tolerated, with no safety issues being identified during its many years of widespread use.
format Online
Article
Text
id pubmed-6267544
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-62675442018-12-11 Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use McKeage, Kate Lyseng-Williamson, Katherine A. Drugs Ther Perspect Adis Drug Q&A EGb 761(®) (Tanakan(®)) is a standardized extract of Ginkgo biloba leaves that has demonstrated protective properties against neuronal and vascular damage. Overall, in randomized, placebo-controlled clinical trials and meta-analyses in adults with mild-to-moderate dementia, EGb 761(®) displayed positive effects, with changes from baseline in outcomes related to cognition, behaviour and global change that are generally better than those shown with placebo. EGb 761(®) is generally well tolerated, with no safety issues being identified during its many years of widespread use. Springer International Publishing 2018-07-11 2018 /pmc/articles/PMC6267544/ /pubmed/30546253 http://dx.doi.org/10.1007/s40267-018-0537-8 Text en © Springer Nature 2018, corrected publication 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
spellingShingle Adis Drug Q&A
McKeage, Kate
Lyseng-Williamson, Katherine A.
Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title_full Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title_fullStr Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title_full_unstemmed Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title_short Ginkgo biloba extract EGb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
title_sort ginkgo biloba extract egb 761(®) in the symptomatic treatment of mild-to-moderate dementia: a profile of its use
topic Adis Drug Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267544/
https://www.ncbi.nlm.nih.gov/pubmed/30546253
http://dx.doi.org/10.1007/s40267-018-0537-8
work_keys_str_mv AT mckeagekate ginkgobilobaextractegb761inthesymptomatictreatmentofmildtomoderatedementiaaprofileofitsuse
AT lysengwilliamsonkatherinea ginkgobilobaextractegb761inthesymptomatictreatmentofmildtomoderatedementiaaprofileofitsuse

Ejemplares similares